Said Dermime|Said Dermine

Said Dermime|Said Dermine

Hamad Medical Corporation - Doha / Qatar
Medical and Health Sciences / Immunology
AD Scientific Index ID: 4698666
person_outline Said Dermime|Said Dermine's MOST POPULAR ARTICLES
1-) The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic … Neoplasia 8 (3), 190-198, 2006
2-) Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines Annals of medicine 54 (1), 524-540, 2022
3-) NY-ESO-1 based immunotherapy of cancer: current perspectives Frontiers in immunology 9, 947, 2018
4-) Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells
5-) CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances Molecular cancer 22 (1), 20, 2023